SC
IMCR icon

Steven Cohen’s Immunocore IMCR Stock Holding History

Steven Cohen’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4M Sell
990,280
-111,991
-10% -$3.31M 0.03% 632
2026
Q1 		$33.2M Buy
1,102,271
+598,120
+119% +$19.3M 0.04% 555
2025
Q4 		$17.5M Sell
504,151
-31,680
-6% -$1.12M 0.02% 986
2025
Q3 		$19.5M Sell
535,831
-284,594
-35% -$9.67M 0.03% 560
2025
Q2 		$25.7M Buy
820,425
+192,133
+31% +$5.97M 0.05% 418
2025
Q1 		$18.6M Buy
628,292
+224,988
+56% +$6.75M 0.04% 462
2024
Q4 		$11.9M Buy
+403,304
New +$12.8M 0.03% 637
2022
Q2 		– Sell
-407,058
Closed -$12.2M – 1500
2022
Q1 		$12.2M Buy
407,058
+394,658
+3,183% +$9.96M 0.05% 460
2021
Q4 		$425K Sell
12,400
-136,600
-92% -$4.95M ﹤0.01% 980
2021
Q3 		$5.52M Buy
149,000
+76,100
+104% +$2.57M 0.02% 641
2021
Q2 		$2.85M Buy
+72,900
New +$2.81M 0.01% 691

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Steven Cohen's IMCR Position: Q2 2026 in Review

Steven Cohen reduced its Immunocore (IMCR) stake by 10% in Q2 2026, selling an estimated $3.31M and leaving 990,280 shares worth $31.4M. The position accounts for 0.03% of the portfolio, ranked #632.

Steven Cohen first reported a position in IMCR in Q2 2021 and has held it in 11 quarters since. The position peaked at $33.2M in Q1 2026. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Steven Cohen held 990,280 shares of Immunocore worth $31.4M as of Q2 2026.
  • Steven Cohen sold 111,991 Immunocore shares in Q2 2026, an estimated $3.31M.
  • Immunocore made up 0.03% of Steven Cohen's portfolio in Q2 2026, its #632 holding.
  • Steven Cohen first reported a position in Immunocore in Q2 2021 and has held it in 11 quarters since.
  • Steven Cohen's Immunocore position peaked at $33.2M in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.